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While cerebellar alterations may play a crucial role in the development of core autism spectrum disorder 
(ASD) symptoms, their pathophysiology on the function of cerebrocerebellar circuit loops is largely 
unknown. We combined multimodal MRI (9.4 T) brain assessment of the prenatal rat valproate (VPA) 
model and correlated immunohistological analysis of the cerebellar purkinje cell number to address 
this question. We hypothesized that a suitable functional MRI (fMRI) paradigm might show some 
altered activity related to disrupted cerebrocerebellar information processing. two doses of maternal 
VPA (400 and 600 mg/kg, s.c.) were used. The higher VPA dose induced 3% smaller whole brain volume, 
the lower dose induced 2% smaller whole brain volume and additionally a focal gray matter density 
decrease in the cerebellum and brainstem. Increased cortical BOLD responses to whisker stimulation 
were detected in both VPA groups, but it was more pronounced and extended to cerebellar regions in 
the 400 mg/kg VPA group. Immunohistological analysis revealed a decreased number of Purkinje cells 
in both VPA groups. In a detailed analysis, we revealed that the Purkinje cell number interacts with the 
cerebral BOLD response distinctively in the two VPA groups that highlights atypical function of the 
cerebrocerebellar circuit loops with potential translational value as an ASD biomarker.
Autism spectrum disorder (ASD) is a lifelong neurodevelopmental disorder1, currently diagnosed using behav-
ioral tests that can be subjective; therefore, objective noninvasive imaging biomarkers of autism are being actively 
researched2–5.
Cerebrocerebellar circuit dysfunction may play a crucial role in the etiology of ASD, as cerebellar lesions or 
structural and functional differences in various cerebellar subregions consistently have been linked to ASD6–11. 
MRI findings of the cerebellum in ASD, however, remain less clear12: although the size of the vermis appears to 
be slightly smaller and structural differences in cerebellar lobule VII (right crus I/II) are associated with core 
ASD symptoms and may have potential functional impact6,7. Similarly, the great majority of a substantial number 
of postmortem anatomical studies of ASD show decreased Purkinje cell density, but with focal regional altera-
tions6,13. Furthermore, a distinct temporally regulated ASD gene module looks specific to developing Purkinje 
cells14.
Neuroanatomical studies underline the extensive and region-specific connectivity between the cerebellum 
and the cerebral cortex with two-stage feed-forward and feed-back loops, e.g., lobules VI/VII (crus I/II) of the 
cerebellum are linked with the association areas of the cerebral cortex concerned with higher order behavior, 
such as the prefrontal cortex, posterior parietal cortex or cingulate gyrus15,16. The anterior part of the cerebellum 
has a sensory domain, in addition to its traditionally known role in motor functions, and the posterior part of 
it contributes to some aspects of affective and cognitive processing17–19. Indeed, cerebellar posterior lobe lesions 
define cerebellar cognitive affective syndrome, and in utero or early postnatal lesions induce behavioral and social 
deficits that overlap with ASD symptoms16,20. Finally, there is recent mechanistic evidence in mice showing that 
in juvenile life the chemogenetic perturbation of the activity of posterior vermal cerebellar regions specifically 
modulates the expression of ASD-related behaviors in adulthood21.
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Despite these seminal findings highlighting the potential functional impact of disrupted cerebrocerebel-
lar loops in ASD8,22, fundamental questions about the pathophysiology of these cerebrocerebellar loops have 
remained unanswered. Equally, their translational utility is unknown, limiting the progress in pursuing objective 
neuroimaging biomarkers in ASD.
We addressed these questions by combining multimodal neuroimaging and correlated immunohistological 
analysis of the cerebellar Purkinje cell number in a prenatal rat valproate (VPA) model. We hypothesized that our 
functional MRI (fMRI) paradigm might show some altered activity related to disrupted cerebrocerebellar infor-
mation processing. We used a somatosensory fMRI paradigm suitable for small animal imaging. Our paradigm, 
by involving nested loops of the whisker system at the cerebellar, midbrain and thalamocortical level23, allocates 
reasonable translational power to sensory-attentional paradigms in human studies. To ensure that our findings 
are reproducible with a time window for potential pharmacological treatments, we performed an MRI assess-
ment of the same cohort twice, with a one-month difference (measurement 1 and 2). Furthermore, in addition 
to a control group with maternal vehicle treatment, due to uncertainty regarding the optimal maternal VPA dose 
triggering changes in somatosensory fMRI activity and/or cerebellar alterations, we investigated two VPA groups, 
with maternal doses of 400 mg/kg and 600 mg/kg (hitherto referred to as the VPA400 and VPA600 groups).
Results
Valproate-induced reduction of cerebellar gray matter and whole brain volume. Because both 
human ASD and its VPA model are known to present specific morphological features, our first assessment was 
to perform volumetry and voxel-based morphometry (VBM) analysis on the structural MRI scans. Anatomical 
scans at measurement 1 revealed that prenatal exposure to VPA resulted in 3.2% smaller whole brain volume in 
the VPA600 group (p = 0.006, effect size: −81.1 mm3) compared to controls. Smaller brain size was also observed 
in gray matter (−3.2%, p = 0.02, effect size: −52.7 mm3) and white matter (−2.4%, p = 0.09, −13.2 mm3) volume; 
however, the latter was not significant. A milder difference in the whole brain volume (−2%, p = 0.06, effect size: 
−51.9 mm3) was observed in the VPA400 group, and this was not detectable either in the gray or in the white 
matter volume. Normalized gray and white matter volumes (calculated on the subject-level as percentage of the 
whole brain volume) were not different between groups. Detailed summary statistics of the volumetry data are 
listed in Supplementary Table 2.
VBM analysis of the structural MRI scans was used to localize the potential gray matter density differences. In 
the VPA600 group, the VBM analysis could not detect any well-localized source of the smaller global gray matter 
volume; there were no normalized voxels showing significantly lower gray matter density (signal intensity modu-
lated by Jacobian determinants) compared to the vehicle group. On the other hand, significantly lower focal gray 
matter density was observed in the VPA400 group in various brainstem nuclei and the bilateral cerebellar crus II 
and paraflocculus compared to controls (Fig. 1). Comparing the VPA400 and VPA600 groups revealed localized 
focal cerebellar and brainstem gray matter alterations only in the VPA400 group, suggesting that this difference 
may specific to the 400 mg/kg prenatal dose. No positive differences in gray matter density were observed in either 
of the VPA groups compared to the VEH group (Supplementary Fig. 6).
BOLD response to whisker stimulation. We assessed the possible ASD-related functional changes in the 
VPA rat model in the sensory domain by somatosensory stimulation-based functional MRI. Whisker stimula-
tion evoked a widespread, significant BOLD response in all three animal groups (Fig. 2A, Supplementary Fig. 6 
and Tables 3–5). As expected, the activation peaked in the barrel field of the primary somatosensory (S1) cortex 
(contralateral to the stimulation side) and in a blob covering the primary auditory (Au1) and the secondary 
somatosensory (S2) cortices. The group-mean maximal signal change in S1 was 0.36%, 0.68% and 0.34% in the 
VEH, VPA400 and VPA600 groups, respectively. The ipsilateral somatosensory activation was weaker but also 
significant in all three groups. Additionally, bilateral striatal, frontal, orbitofrontal, insular, entorhinal, cerebellar, 
and amygdalar as well as brainstem (trigeminal) activations were found in all three groups. Local maxima and 
effect sizes are reported in Supplementary Tables 3–5. In general, group-level activation was the most extended in 
the VPA400 group (455.8 mm3), followed by the VPA600 (225.2 mm3) and the vehicle (190 mm3) groups.
Functional hyperactivation as a consequence of prenatal valproate exposure. Between-group 
fMRI analysis contrasts revealed that several of the striking differences of the groupwise activation patterns were 
statistically significant (Fig. 2B, Table 1). A remarkable and robust effect of prenatal VPA exposure was the wide-
spread increase in the BOLD response to whisker stimulation (Fig. 2B, Table 1). In both the VPA400 and VPA600 
groups, pronounced hyperactivation was found in the primary somatosensory, ventral orbital, anterior cingular 
and frontal association cortices.
Contrasting the VPA400 and VPA600 groups revealed stronger hyperactivation in the VPA400 group, espe-
cially in regions of the primary somatosensory (contralateral to stimulation), ventral orbital, and frontal associa-
tion cortices (Table 1) but also in the cerebellar lobule VIII and crus II (Table 1).
Repeated MRI assessment of the functional and structural alterations. Measurement 2 (per-
formed one month later) reproduced the results of measurement 1, indicating that most of our MRI findings 
persevered (Fig. 3C–F).
Despite the overall increase in the brain volume of all groups (+3.2%, from 2564.8 mm3 to 2646.4 mm3 in the 
VEH group, see Supplementary Table 1), a 3.6% difference between the VPA600 and the VEH group still persisted 
(p = 0.0007, effect size: −97.9 mm3). This difference was also present in absolute gray matter volume (−3.3%, 
p = 0.005, effect size: −54.5 mm3). Normalized gray and white matter volumes (calculated on the subject-level as 
percentage of the whole brain volume) did not differ between groups.
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The VBM analysis of measurement 2 demonstrated decreased gray matter density in cerebellar and brainstem 
locations of the VPA400 group with a remarkable overlap with measurement 1 (Fig. 3F). The decrease was also 
observed in contrast to the VPA600 group, while there was no change in gray matter density in any other group 
contrast.
In measurement 2, the group-level spatial pattern of whisker stimulation-induced BOLD activations were 
similar to those of measurement 1 (Supplementary Fig. 1.), although with smaller magnitudes due to the higher 
isoflurane doses. This and the smaller sample size due to exclusions (e.g., in-scanner motion; N = 33) resulted in 
a decreased statistical power. Nevertheless, we were still able to detect functional hyperactivation in the VPA400 
group compared to the vehicle group. The hyperactivation was significant in a cluster in the primary somatosen-
sory cortex (contralateral to stimulation, cluster-level correction for multiple comparisons, Pclust = 0.045, cluster-
wise mean increase in effect size: 0.28%, see Supplementary Figs 2 and 3).
As mentioned above, due to the greater weight of the animals at measurement 2, more isoflurane was needed 
to maintain a comparable level of anesthesia and respiration rate (Supplementary Table 1). Since higher isoflu-
rane doses dramatically affect neuronal activity and have vasodilatory action, these are unfavorable effects on 
the magnitude of BOLD responses24. Therefore, direct comparison or pooling of the measurements would be 
inappropriate and we regard measurement 2 merely as a confirmatory measure.
Decreased cerebellar purkinje cell number revealed by calbindin D28k immunostain-
ing. Because lower Purkinje cell density is one of the most reproduced cerebellar postmortem anatomical 
findings in ASD, we made calbindin D28k (CB) immunostained sagittal sections from the cerebellar vermis of 
27 rats (9 from each group). We found that the number of CB-positive Purkinje cells was significantly lower in 
both VPA groups compared to the VEH group (Fig. 4) in all lobules tested (6a, 6b, 6c, 7). The difference was a 
larger magnitude in the VPA400 group. All p-values were smaller than 0.005, implying very strong evidence of 
Purkinje cell loss. In all lobules, the magnitude of the Purkinje cell number decrease was stronger in the VPA400 
group (−30.7%, −47.9% −29.2% and −32.6% in lobules 6a, 6b, 6c and 7, respectively) than in the VPA600 group 
(−21.4%, −19.5%, −26.3% and −24.3% in lobules 6a, 6b, 6c and 7, respectively). Staining intensity did not affect 
the quantification. Summary statistics of normalized Purkinje cell numbers found by calbindin D28k immunos-
taining are listed in Supplementary Table 6.
Figure 1. Decreased cerebellar and brainstem gray matter density revealed by voxel-based morphometry 
analysis. Evidence of cerebellar (crus II and paraflocculus) and brainstem (ventral nu. lat. lemniscus) lower 
focal gray matter density in the VPA400 group compared to both the VEH (top) and the VPA600 (bottom) 
groups (measurement 1). Compared to the VEH group, no decreases in VPA600 group and no increases in 
either of the VPA groups were observed. These results, together with the tissue volumetry analysis (Fig. 3), 
show that both VPA doses induced smaller whole brain volume while only the 400 mg/kg VPA dose induced 
detectable, focal localized cerebellar and brainstem gray matter alterations. On the top right of the figure, the 
position of slices (and their distance from bregma in mm) are shown on sagittal and horizontal planes. The 
colorbar represents Z-score (Gaussianized T-score) values of the parametric images (TFCE enhanced FDR-
corrected significance threshold of P = 0.05). The slices highlight significant clusters (meaning that there are 
no significant changes in the cerebrum). Parametric images are overlaid on the study specific gray-matter 
probability map. Yellow overlay: Paxinos rat brain atlas. Images are shown in neurological convention (left-is-
left; A: anterior, P: posterior, L: left, R: right; Crus II: crus II; PFI: paraflocculus).
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Figure 2. BOLD hyperactivation in response to somatosensory stimulation after prenatal valproate exposure. 
(A) Whisker stimulation triggered activation mainly in the contralateral primary and secondary somatosensory 
cortices (S1 and S2, respectively), auditory cortices (Au1) and the trigeminal nuclei of the brainstem. (B) 
BOLD response differences in the VPA400 and VPA600 groups compared to the VEH control group showed 
a robust activation increase in S1, anterior cingulate cortex (Cng), frontal areas (IL: infralimbic cortex, VO: 
ventral orbital cortex) and brainstem lateral lemniscus in the VPA400 group. A spatially restricted decrease 
was also observed on the cerebellar surface in this group. A similar but less prominent frontal and ipsilateral 
somatosensory hyperactivation was observed in the VPA600 group and involved the primary motor cortex 
(M1). Activations are displayed on coronal slices, overlaid on an in-house standard proton-density template. On 
the top right of each panel, the position of the slices are displayed on sagittal and horizontal planes as a distance 
from bregma in mm. Colorbars represent Z-score values. Significance thresholding was corrected for multiple 
comparisons (P = 0.05). Abbreviations: A: anterior, P: posterior, L: left, R: right.
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Correlation of the BOLD response with the cerebellar purkinje cell number. To the best of 
our knowledge, it is not known how lower Purkinje cell number is related to abnormal brain function in the 
VPA-model of ASD. Here, we analyzed how the correlation of individual Purkinje cell number and BOLD 
response to somatosensory stimulation is related to prenatal VPA exposure. In the VPA400 group (in animals 
with histological data available), a significant positive correlation of BOLD response with cerebellar Purkinje cell 
number was found in the frontal and cerebellar areas (Fig. 5B, Supplementary Table 10). In contrast, the VPA600 
group exhibited a significant negative correlation in cortical and cerebellar regions (Fig. 5C, Supplementary 
Table 11). No significant correlation was found in the control group (Fig. 5A).
Interaction effect of cerebellar purkinje cell number and valproate treatment on the cerebel-
lar and cerebral BOLD response. To capture VPA exposure-related effects, the differences in the group-
wise “BOLD-Purkinje” correlation maps were further investigated by an interaction analysis. This revealed that 
Figure 3. Persevered prenatal valproate-induced alterations demonstrated by a repeated MRI assessment of 
brain structure and function. (A) fMRI statistical parametric maps (at a coronal slice 2.8 mm from bregma in the 
posterior direction) of group-mean BOLD responses to whisker stimulation (right side) in the three experimental 
groups measured with one month difference. (B) Boxplots represent the average BOLD response in an unbiased 
somatosensory ROI (pooled-group mean activation Z-score > 9). Note the reproducible hyperactivation in the 
contralateral somatosensory cortex in the VPA400 group, in both measurements. (C,D,E) Boxplots depict the volume 
(mm3) of the whole brain, gray matter and white matter, respectively. The VPA600 group exhibits a significantly 
decreased whole brain volume and gray matter volume in both measurements, despite the overall increase in brain 
volume. (F) Bilateral cerebellar and brainstem gray matter density decreases found by VBM in the VPA400 group 
compared to both the VEH group (left image in both panels) and the VPA600 group (right image in both panels), 
consistently in both MRI measurements. Inset zooms into small details of the image, revealing a spatially limited 
cluster of difference. Colorbars represent Z-score values. Statistical images are thresholded at a corrected threshold 
of FWER P < 0.05. Images are displayed in neurological convention (left-is-left). Boxes in the boxplots represent the 
75th, 50th (median), and 25th percentile, whereas whiskers represent either the extrema or twice the interquartile 
range. Observations falling outside the 2*IQR range are represented by points. P-values lower than 0.1 (contrasting 
VPA groups to the VEH) are shown at the boxplots.
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the regression slopes between BOLD response and Purkinje cell number in the medial frontal cortex and in a 
small cerebellar region are significantly larger in the VPA400 group than in the vehicle group (Fig. 5D). We also 
observed areas of significant interaction in the VPA600 group. Here, the interaction coefficient was negative, 
implying that the regression slopes between BOLD response and Purkinje cell number in some cerebellar and 
somatosensory regions are significantly smaller (in fact, more negative) in the VPA600 group than in the vehicle 
group (Fig. 5D). The significant cerebral interaction between VPA treatment and Purkinje cell number suggests a 
VPA-induced cerebrocerebellar malfunction that is unseen when only focused on the cerebellum.
To gain a more direct insight into the treatment x Purkinje interaction effect on BOLD response, we conducted 
an ROI analysis. We defined two unbiased ROIs and investigated the effect of cerebellar Purkinje cell number on 
the individual ROI-mean cerebellar and cerebral BOLD responses. Analysis of the cerebellar ROI (left part of 
Fig. 6) revealed a general positive correlation between cerebellar BOLD response and Purkinje cell number in 
the VEH group. No such correlation was observed in the VPA600 group; however, the values might represent 
the naturally continuing trajectory of the relationship seen in the VEH group, but in ranges of the lower Purkinje 
numbers, where the BOLD response already converges to zero. In contrast, the strong positive correlation in the 
x y z % Signal change Z-score Region
VPA400 > VEHICLE
3.1 −0.4 −1.2 0.42 6.89 S1FL primary somatosensory cortex forelimb
−1.5 3.2 −5.2 0.40 7.65 VO ventral orbital cortex
−5.1 −3.0 −2.8 0.31 4.97 S1BF primary somatosensory cortex barrel field
2.7 3.4 −4.4 0.29 6.68 LO lateral orbital cortex
1.1 0.6 −2.2 0.28 5.81 Cg1 cingular cortex
−7.7 −4.0 −6.8 0.20 6.83 Ect ectorhinal cortex
2.1 4.8 −2.2 0.17 5.98 FrA frontal association cortex
−4.5 0.8 −8.6 0.16 4.80 Pir piriform cortex
2.9 2.8 −6.0 0.16 4.49 VO ventral orbital cortex
2.3 1.0 −6.8 0.16 5.22 CPu striatum
−2.7 −8.6 −7.6 0.15 4.75 brainstem (lateral lemniscus)
−7.3 −3.4 −4.4 0.15 6.09 Au1 primary auditory cortex
2.5 −8.2 −7.6 0.14 4.64 brainstem (lateral lemniscus)
−7.7 −5.0 −7.4 0.12 4.41 Ect ectorhinal cortex
VPA600 > VEHICLE
2.5 −0.4 −1.2 0.51 6.91 S1HL primary somatosensory cortex hindlimb
1.9 2.0 −2.4 0.35 7.47 M1 primary motor cortex
3.3 2.4 −1.6 0.30 4.47 M1 primary motor cortex
5.3 −2.8 −2.8 0.30 4.33 S1BF primary somatosensory cortex barrel field
3.1 −0.6 −2.0 0.29 4.90 S1FL primary somatosensory cortex forelimb
−0.9 −5.2 −6.0 0.23 4.31 thalamus
−1.5 3.0 −6.2 0.22 4.71 VO ventral orbital cortex
2.1 4.6 −2.2 0.15 4.44 FrA frontal association cortex
−7.3 −3.4 −4.4 0.14 4.30 Au1 primary auditory cortex
4.5 3.0 −5.8 0.06 5.01 AIV agranular insular cortex
VPA400 > VPA600
−5.1 −3.0 −2.8 0.37 5.55 S1BF primary somatosensory cortex barrel field
1.1 4.4 −4.4 0.36 8.50 VO ventral orbital cortex
−1.3 5.0 −2.4 0.24 4.78 FrA frontal association cortex
5.1 1.4 −2.8 0.22 4.98 S1J primary somatosensory cortex jaw
−7.7 −4.4 −6.8 0.20 6.17 Ect ectorhinal cortex
3.7 −1.0 −5.2 0.19 4.58 CPu striatum
−2.9 −8.8 −7.4 0.16 4.90 brainstem (lateral lemniscus)
−0.5 −13.4 −5.4 0.14 5.05 lobule VIII cerebellum
−2.7 −11 −7.4 0.14 4.48 brainstem (lateral lemniscus)
−2.3 −14.0 −4.8 0.13 5.06 lobule VIII cerebellum
−2.5 5.4 −2.6 0.12 4.46 FrA frontal association cortex
2.3 −13.0 −6.2 0.11 4.30 crus II cerebellum
4.7 −13.4 −6.2 0.10 4.50 crus II cerebellum
3.7 3.8 −6.0 0.09 4.58 LO lateral orbital cortex
Table 1. Local maxima of the change of the fMRI BOLD response in the VPA400 and VPA600 groups 
compared to the VEH control group. Only local maxima above the FWER P > 0.05 threshold (|Z| > 4.29) are 
shown. The minimum peak distance is set to 3 mm. Peaks are listed by effect size (% BOLD signal change) in 
decreasing order. Coordinates are given relative to bregma, according to the atlas of Paxinos and Watson (x: 
medial-lateral, y: anterior-posterior, z: dorsal-ventral).
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VPA400 display no continuity to the VEH group. In this case, despite the remarkable decrease in Purkinje cell 
number, the BOLD responses were comparable to those of the controls.
In the cerebral activation areas (right side), both the VEH and the VPA600 groups exhibited a significant neg-
ative correlation between BOLD response and Purkinje cell number. However, this relationship became positive 
in the VPA400 group. The difference in slopes was captured by a significant interaction effect. Despite the lower 
BOLD responses due to anesthesia-related issues with larger animals, the second MRI measurement confirmed 
the tendency of a positive correlation between BOLD response and Purkinje cell number (Supplementary Fig. 5)
Discussion
Although autism has a strong genetic component, there are many cases of autism, termed “idiopathic”, that are 
likely influenced by environmental factors25. Animal models of idiopathic ASD include either inbred rodent 
strains that mimic ASD behaviors or models developed by environmental interventions such as prenatal expo-
sure to VPA26. This model of ASD exhibits face, construct and predictive validity and properly represents the 
epigenetic origin of idiopathic ASD27,28. While a few reports have already examined cerebellar anomalies in the 
prenatal VPA rodent model29–32, the relationship of the abnormal Purkinje cell number to the function of cere-
brocerebellar circuitry has not yet been investigated.
ASD-like cerebral and cerebellar structural changes. In our study, brain volume decrease was globally 
detected in the VPA600 group. In preclinical studies, even higher prenatal dose regimens are often used with sim-
ilar results30,33; however, the observed magnitude of whole brain volume differences might be somewhat severe. 
On the other hand, in case of the smaller dose (VPA400 group), beside milder brain volume decrease, focal, cere-
bellar gray matter differences were detected (Fig. 1) which might be an autistic-like morphological feature. These 
morphometric alterations localized in the cerebellar crus II and paraflocculus (in both measurements) compared 
to the VEH control group and the VPA600 group. The paraflocculus could be involved in atypical gaze34, the 
posterior cerebellar vermis (vermal lobules VI-VII) in repetitive behaviors and stereotyped interests in ASD35. 
Figure 4. Prenatal valproate exposure induced reductions in cerebellar Purkinje cell number. (A) Light 
micrograph of calbindin D28k (CB) immunostained sagittal section of rat cerebellar vermis at low 
magnification. (B) Boxplots representing normalized CB immunoreactive Purkinje cell numbers in cerebellar 
vermal lobules 6a, 6b, 6c and 7, for the VEH, VPA400 and VPA600 groups. Asterisks depict significant 
(p < 0.05) decreases compared to the VEH group. (C,D) Normal distribution of CB immunoreactive Purkinje 
cells in the ganglionic layer of cerebellar cortex on VEH sections. (E–H) Decreased CB-positive Purkinje cell 
number, found both in the VPA400 and VPA600 groups. The arrows point to unlikely large areas with lack of 
Purkinje cells. Scale bars: 1000 μm (A), 100 μm (C,E,G), 20 μm (D,F,H).
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Crus I/II abnormalities are related to more severe ASD impairments in all domains7 with altered functional con-
nectivity to specific cerebral regions11,36,37.
Our structural MRI findings in this model are in line with similar studies on absolute brain mass in early post-
natal life, demonstrating reduced brain mass after 500 mg/kg VPA exposure38, and microencephaly (on E14 and 
E18) followed by macroencephaly (on P2 and P7) after 400 mg/kg VPA exposure39. Several human studies have 
suggested divergent age effects on brain morphology changes in ASD40, with a more rapid age-related cortical 
thinning in temporal and parietal regions compared to controls41. Decreased thickness in the temporal cortex 
was reported recently from a large multinational sample of the ENIGMA ASD working group, while at the same 
time, increased cortical thickness in the frontal cortex was found42. Similarly, using data from the multicenter 
Figure 5. Prenatal valproate changes in the correlation of BOLD response and Purkinje cell number are 
present in both the cerebellum and the cerebral cortex. (A) No significant correlation of BOLD response (from 
measurement 1) with Purkinje cell number in the control group. (B) Significant positive interrelationship in 
the frontal and cerebellar areas in the VPA400 group. (C) Negatively correlated cortical and cerebellar regions 
with Purkinje cell number in the VPA600 group (D) Significant interaction effect between Purkinje cell number 
and treatment group on the BOLD response in a frontal and a cerebellar region of the VPA400 group (left 
side) and in somatosensory and cerebellar regions of the VPA600 group. Compared to controls, red indicates 
a greater regression slope in the VPA400 group, and blue denotes a lower slope in the VPA600 group. The 
distance of slices from bregma are shown under the slices. For effect sizes, see Supplementary Tables 12 and 13. 
Activations are displayed on coronal slices, overlaid on an in-house standard proton-density template62. On 
the top right, the positions of the slices are shown on sagittal and horizontal planes as a distance from bregma 
in mm. Colorbars represent Z-score values. Significance thresholding was corrected for multiple comparisons 
(P = 0.05). Abbreviations: A: anterior, P: posterior, L: left, R: right.
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repository, the ABIDE initiative, a surface-based cortical thickness analysis revealed an increase in prefrontal 
cortical thickness in ASD43. Remarkably, an inverse correlation had been found earlier between the sizes of the 
frontal lobe and cerebellum in ASD44, reflecting an abnormal overgrowth in the frontal lobes45.
Sensory BOLD hyperactivation induced by prenatal valproate exposure. Sensory abnormali-
ties are known in ASD (DSM-5, diagnostic criteria B.4.) Somatosensory evoked potentials show hyperactivity 
in infantile autism46 as in Fmr1(−/y) mice47; therefore, sensory hypersensitivity may have translational value. 
Prenatal VPA rats have also shown increased sensory reactivity to mechanical stimuli48 and increased neuronal 
activation in the auditory brainstem after sound exposure49. Interestingly, local functional overconnectivity was 
not demonstrated in the somatosensory cortex of ASD individuals by magnetoencephalography, challenging the 
theory that the primary substrate of hypersensitivity is localized in the somatosensory cortex50.
In our fMRI measurement, the presence of altered sensory processing was reinforced in the prenatal VPA 
model of autism. The BOLD hyperactivation was more pronounced in the VPA400 group, but it was also clearly 
present in the VPA600 group. BOLD hyperactivation was prominent in areas with a significant group-mean 
response in the VEH group, and frontal hyperactivation, including the lateral and ventral orbital, prelimbic, 
frontal association, and anterior cingular cortices, was also found in the VPA groups. In the VPA400 group, there 
were additional activations in the brainstem (lateral lemniscus) and cerebellar regions (specifically in the crus II); 
however, these cerebellar activations proved to be significant only when compared to the VPA600 group.
Although both the morphometric alterations found in our VBM analysis and the cerebellar hyperactivations 
in the VPA400 group were localized in nonsensorimotor areas of the cerebellum (paraflocculus and crus II), 
a direct link of structural changes to the observed sensory hyperactivation might also be possible, since there 
Figure 6. Atypical relationship between BOLD response and Purkinje cell number in cerebellar and cerebral 
ROIs of the pooled activation maps, suggesting probable malfunction of reciprocal cerebrocerebellar circuits. 
ROIs (visualized in 3D glass-brains) were defined based on the F-contrast representing the unbiased, 
pooled activation map, thresholded at FWER p < 0.05 and divided into cerebellar (left) and cerebral (right) 
components. Analysis of the cerebellar ROI (left column) revealed a general positive correlation between frontal 
BOLD response and Purkinje cell number in the VEH group. No such correlation was observed in the VPA600 
group. Despite the remarkable decrease in Purkinje cell number in the VPA400 group, BOLD responses, in 
terms of both magnitude and correlation with Purkinje cell number, were comparable to those of the controls. 
In the cerebral ROI (right panel), both the VEH and the VPA600 groups exhibited a significant negative 
correlation between BOLD response and Purkinje cell number. Interestingly, the correlation was positive in the 
VPA400 group, which possibly indicates the presence of an atypical cerebrocerebellar circuit in this VPA group. 
Abbreviations: A: anterior, P: posterior, L: left, R: right, S: superior, I: inferior.
1 0Scientific RepoRts |          (2019) 9:9225  | https://doi.org/10.1038/s41598-019-45667-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
is evidence for a noncanonical organization of cerebrocerebellar circuits in ASD, especially in the sensory 
domain51,52. Since the paraflocculus has projections to the brainstem and the crus II normally interconnects with 
frontal and parietal areas, the brainstem (lateral lemniscus) and frontal components of the BOLD hyperactivation 
might also reflect the consequences of noncanonically organized cerebrocerebellar circuits. Consistent with this 
interpretation, abnormal cortical connectivity of the crus I/II region has been found in ASD7,8,11.
Atypical effect of decreased Purkinje cell number on cerebrocerebellar activity. Following 
current ideas about the atypical functional connectivity of cerebrocerebellar circuit loops in ASD7,8,51–54, it is 
straightforward to hypothesize that the significant VPA-induced decrease in Purkinje cell number might have 
a developmental effect on the cerebral cortical regions the cerebellum functionally connected with8,22. We 
addressed this assumption by testing the groupwise correlation of BOLD response and Purkinje cell number and 
whether it was different between groups (evaluating the “treatment x Purkinje cell number” interaction effect on 
the BOLD response).
In the case of the cerebellar BOLD signal, the main contributor to the activity is the parallel/mossy fiber sys-
tem55, and the contribution of the Purkinje cell activity might be relatively small56. Therefore, instead of simply 
reflecting the summed activity of Purkinje cells, the positive correlation between BOLD response and Purkinje 
cell number observed in the control group might be driven by the indirect effect of increased cerebral input 
through the parallel/mossy fiber systems.
On the other hand, throughout the cerebral activation areas, the BOLD - Purkinje cell number correlation is 
negative in the control group, which might be either a consequence of a stronger modulatory/inhibitory effect 
in the presence of more Purkinje cells or might be caused by some neurodevelopmental source affecting both 
Purkinje cell development and the maturation of distant cerebral circuits. Indeed, on the Purkinje cell level, 
prenatal VPA exposure delayed the developmental excitatory/inhibitory GABA “switch”57, supporting a role of 
developmental timing in the pathophysiology of ASD.
The correlation of the BOLD response and Purkinje cell number is strongly dependent on the dose of VPA 
exposure. The simplest explanation for the significant “group x Purkinje cell number” interaction in the VPA600 
group is that they represent a naturally continuing, nonlinear trajectory of the VEH group but in ranges of sig-
nificantly lower Purkinje cell numbers, where the BOLD response already saturates to zero (thereby introduc-
ing a difference in linear regression slopes; also visible in Fig. 6). However, this explanation does not hold for 
the VPA400 group. Here, our results suggest that, despite the lower Purkinje cell numbers, the BOLD-Purkinje 
correlation maintained at similar or even higher levels than those of the control group, possibly by means of 
some compensatory mechanisms. Importantly, this “compensated” cerebellar BOLD response is accompanied by 
an atypical effect on cerebral responses, where the BOLD-Purkinje correlation turns from negative to positive. 
Notably, the atypical BOLD-Purkinje correlation is most pronounced in the frontal activation areas, support-
ing our hypothesis that noncanonically organized cerebrocerebellar circuits are present between the crus II and 
frontal regions. This might be a sign of a drastic VPA-related change in cerebrocerebellar modulation and/or a 
consequence of VPA-induced developmental diaschisis22. While the underlying mechanism remains unclear, our 
results demonstrate that measurable correlations exist in the VPA model between the cerebellar morphology and 
cerebrocerebellar circuit loop function.
Limitation of the study. In order to avoid interference between behavioral testing and MRI measure-
ments, the ASD-like phenotypes were not assessed in the same rats involved in the MRI study. Although the 
compatibility to ASD-like phenotypes in the different rodent VPA models was reviewed recently58, data from 
ASD-related behavioral tests measured in a cohort reared independently from the MRI cohort are provided in the 
Supplementary Material (Supplementary Figs 7–9). In these tests both VPA400 and VPA600 rats had unaffected 
spontaneous locomotor activity, while both VPA groups were impaired in the social novelty test. Interestingly 
only the VPA400 group exhibits alteration in juvenile social play test at postnatal day 33-36 (Supplementary 
Fig. 8).
Conclusion
In this multimodal MRI study of the VPA rat model of ASD, we found (i) ASD-like global and cerebellar changes 
in brain morphology, (ii) a functional BOLD hyperactivation to whisker sensory stimuli and (iii) distinct corre-
lations between the cerebellar Purkinje cell number and cerebral BOLD responses in the two VPA groups. Our 
results suggest an altered interaction between the cerebellar and frontal cerebral areas. These alterations in the 
rat VPA model of ASD have potential translational value in the search for objective neuroimaging biomarkers in 
ASD.
Methods
subjects. Timed-mated female Sprague-Dawley rats (Harlan, San Pietro al Natisone, Italy) arrived at the local 
vivarium at gestational day 6-8. Animals were kept in polycarbonate cages in a thermostatically controlled room 
at 21 ± 1 °C. The room was artificially illuminated from 6 a.m. to 6 p.m. The rats were fed conventional laboratory 
rat food (sniff R/M + H Spezieldiäten GmbH D-59494 Soest). All of the procedures conformed to the guide-
lines of the National Institutes of Health for the care and use of laboratory animals, were approved by the Local 
Ethical Committee of Gedeon Richter Plc. and were carried out in strict compliance with the European Directive 
2010/63/EU regarding the care and use of laboratory animals for experimental procedures. All efforts were made 
to minimize the number of animals as well as their suffering. Experiments were performed and reported accord-
ing to the ARRIVE guidelines on animal research.
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Gestational valproic acid administration. The timed-pregnant female Sprague-Dawley rats received a 
single subcutaneous dose of 400 or 600 mg/kg sodium VPA (Sigma-Aldrich Chemical Co, UK) or vehicle (saline 
injection) in the loose skin area of the neck in a volume of 1 ml/kg dissolved in sterile physiological saline at ges-
tational day 12.5 as described previously59. The treatment groups are referred to as VEH, VPA400 and VPA600. 
On postnatal day 21, male offspring were weaned and housed in groups of 3 or 4.
Age of the animals during the MRI experiments. During measurement 1 the animals were seven weeks 
old and during measurement 2 the animals were eleven weeks old. For weight, average in-scanner motion, isoflu-
rane dose and respiration rate see Supplementary Table 1.
Image acquisition. Before magnetic resonance imaging, animals were habituated to the acoustic noise of 
the MRI scanner for 1 week in a separate animal room. In the experiments, 36 male rats (12 rats from each treat-
ment group) were used. The mean (±standard deviation) initial weight of the rats was 209 (±27) g over the first 
MRI measurements (performed in a period of two weeks) and 393 (±23) g over the second MRI measurements 
(beginning one month after the end of the first measurement). Four rats were scanned per day in a random order 
from each treatment group.
On the day of scanning, rats were anesthetized before transporting to the magnet room. Anesthesia was introduced 
with 5% isoflurane and then maintained at approximately 1.25% during scanning. The body temperature was main-
tained at 38 ± 1 °C with thermostatically controlled air flow around the rat. The respiration of the animal was monitored 
continuously with a small pneumatic pillow sensor during the experiment (SA Instruments, Inc., NY, USA).
The MRI experiments were performed using a 9.4 T Varian MRI system (Varian Associates Inc., Palo Alto, 
CA) with a free bore size of 210 mm, which contained a 120 mm inner size gradient coil (minimum rise time 140 
μs; 200 μs were used). For excitation, an actively RF-decoupled 2 channel volume coil system with an inner size of 
70 mm was used, and a fixed-tuned receive-only phase array rat brain coil (RAPID Biomedical GmbH, Rimpar, 
Germany) was located directly above the dorsal surface of each rat’s head to maximize the signal-to-noise ratio.
For the spatial coregistration of fMRI scans and for voxel-based morphometry (VBM), proton density 
weighted anatomical scans were acquired using gradient echo multi-slice imaging (GEMS; echo time (TE): 
5.78 ms, repetition time (TR): 855 ms, flip angle: 40°, data matrix: 256 × 256, total scan time: 22 min 30 s) 
sequence with a field-of-view (FOV) of 40 mm × 40 mm and a slice thickness of 0.2 mm, without interslice gap. 
Seventy-four slices were acquired in an interleaved order. Anatomical scans were repeated 8 times and then aver-
aged into a single image.
MRI measurements: anesthesia, respiration and motion. Since motion artifacts are very problematic 
in MRI, before any further analysis, we examined the magnitude and between-group differences in in-scanner 
motion, respiration and anesthetic dose. Despite the superficial anesthesia during functional MR imaging, motion 
was moderate throughout all MRI experiments (Supplementary Table 1). For both MRI measurements, weight, 
average in-scanner motion (as estimated by the motion correction algorithm), isoflurane dose and respiration 
rate were not different between the groups. Summary statistics of these measures are listed in Supplementary 
Table 1.
Functional MRI experiments. The T2*-weighted echo planar imaging (EPI) sequence for the fMRI experi-
ments had the following settings: TE: 10 ms, TR: 2030 ms, flip angle: 90°, averages: 1, dummy scans: 4, data matrix: 
50 × 50, 400 repetitions, FOV: 40 mm × 40 mm, slice thickness: 0.8 mm, no interslice gap, and 16 horizontal slices 
(resolution: 0.8 × 0.8 × 0.8 mm3). For the reduction of the EPI Nyquist ghost artifact, a triple reference scan60 was 
used, meaning that the functional images were acquired with two opposite gradient polarities, which resulted in 
an effective TR of 4060 ms.
For a somatosensory stimulus, pneumatic “air-puffed” whisker stimulation was used in a block-design fashion. The 
stimulation was delivered to the right whisker pad of the animals through a tubing system that was integrated into the 
holding cradle. The air pressure was set to 1 bar. Air puffs were delivered at a frequency of 1 Hz with a blowing time of 
200 ms. The duration of the stimulation blocks was 30 s followed by a 60 s rest. Over one experimental session, 6 blocks 
of stimulation were used. The pneumatic stimulation was controlled by a custom-programmed user interface devel-
oped in LabView (National Instruments Corporation, Austin, TX, USA).
Exclusion criteria. Exclusion criteria were fixed prior to data analysis as follows: scans with striking imaging 
artifacts (based on visual inspection) or with an average root mean squared relative displacement greater than 
0.05 mm during the fMRI scan (as calculated by FSL) were subject to exclusion from all analyses.
Moreover, subjects without immunohistological data were excluded from the analyses focusing on the corre-
lation of BOLD response with Purkinje cell number and its group-level interaction.
None of the scans had to be discarded due to artifacts or in-scanner motion issues, resulting in N = 36 for the 
whole-brain fMRI analysis of the first measurement. On the other hand, in the second measurement, 3 animals 
had to be excluded because of in-scanner motion and inadequate anesthesia (2 controls and 1 in the VPA600 
group), resulting in N = 33.
The immunohistology experiments were only performed for N = 9 animals per group, and one animal from 
the VPA600 group had to be excluded for technical reasons.
Imaging data analysis. To obtain maximally translatable results, we followed the conventions set for 
human MRI analysis, similar to our previous works61,62. Small-animal imaging-specific features of the applied 
image processing pipeline are described in detail. When not specified otherwise, the same data analysis steps were 
performed in the first and second MRI measurements.
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preprocessing. The raw images were converted to NIfTI-format (Neuroimaging Informatics Technology 
Initiative) by an in-house developed script. The anatomical and functional images were reoriented to match the 
standard orientation of the digitalized version of the Rat Brain Atlas of Paxinos and Watson63. All images were 
rescaled by a factor of ten to achieve image dimensions similar to human data and thus facilitate the use of 
image processing algorithms developed for human image analysis. All the approaches performed on the upscaled 
images were scale-invariant, except for a built-in constraint optimization for motion correction. The upscaling 
only affects the dimension descriptor fields in the file header and does not involve interpolation or any infor-
mation loss. The analysis was carried out in a multistage process using the image analysis software package, 
FSL64 (FMRIB’s Software Library, www.fmrib.ox.ac.uk/fsl), and in-house developed software tools. All the fMRI 
time-series were motion-corrected using MCFLIRT65. FSL BET (Brain Extraction Tool66) was used to remove 
nonbrain areas from the structural and functional images. The fractional intensity threshold was set to 0.65 and 
0.7 for functional and structural images, respectively, and the vertical gradient in the fractional threshold was set 
to 0.1. Before the brain extraction, the images were rescaled in the y-direction by a factor of 0.5 to ensure that the 
spherical brain model used by BET gained robust segmentation results. The brain-extracted images were then 
rescaled to the original y-axis dimensions.
To achieve spatial correspondence for the group analysis, all images were spatially standardized using FSL 
FLIRT67, which utilized a 6-parameter rigid-body transformation. The high-resolution structural image was fitted 
to an in-house developed standard template62 (average of 200 nonlinearly fitted structural images) by an affine 
transformation (FLIRT) and a nonlinear deformation field estimated by FNIRT68. In the latter coregistration pro-
cedure, a 10 × 10 × 10 mm3 warping field (in upscaled space) was estimated with three iterations using a relatively 
conservative lambda parameter set of 60, 40 and 20. This stricter regularization was applied as the morphological 
diversity of the rat brain is smaller compared to humans.
Voxelwise functional MRI (fMRI) analysis. Before the statistical analysis, the functional images were 
spatially smoothed using a Gaussian kernel of 12.0 mm FWHM (note that the images were upscaled). High-pass 
temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma = 140.0 s) was then applied 
to remove slow drifts from the signal. The fMRI data processing was carried out using FEAT (FMRI Expert 
Analysis Tool) Version 6.00, part of FSL. After signal prewhitening (FILM), the first-level statistical analysis on 
the time-series was carried out using the general linear model with local autocorrelation correction69. The analysis 
modeled each individual rat’s data from each session and included 7 explanatory variables in total: one regressor 
modeling the stimuli (convolved with a double-gamma canonical HRF), its temporal derivate, to account for 
slight differences in timing and 5 noise-ROI-based, CompCor70 confounder variables. For each fMRI session, a 
noise ROI was delineated based on the temporal signal-to-noise ratio of the BOLD signals (the upper 2 percen-
tiles of within-brain voxels were chosen on each slice), and the first five principal components of the correspond-
ing time-series were extracted from the data, following the broadly used t-CompCor technique70. Individual 
statistical Z-score images for the first regressor were obtained (average BOLD response to the stimuli).
Using the spatial transformations computed during image coregistration and standardization, Z-score maps 
resulting from the individual statistical analysis were realigned to the common standard space to achieve spatial 
correspondence during the group-level voxelwise analysis.
A second-level general linear model analysis was performed with FEAT. Data from the first and second meas-
urements were analyzed separately. Three different statistical models were evaluated for both measurements.
Model 1 was a simple model with three explanatory variables modeling the treatment groups with dummy 
coding (N = 36 and 33 for measurement 1 and 2, respectively). Statistical contrasts were defined to assess the 
VPA400 vs. VEH., VPA600 vs. VEH and VPA400 vs. VPA600 comparisons. An F-contrast was also specified to 
establish a statistical map of voxels activated in at least one of the three groups. This map was used for defining 
unbiased ROIs.
Model 2 was a model analogous to Model 1 but with the restricted population for which histological data were 
also available (N = 25, for both measurements). The goal of this model was simply to demonstrate that the results 
of model 1 are not driven by animals excluded from further analysis (that is, the restricted population is still rep-
resentative in terms of findings in the whole population).
Model 3, next to the three explanatory variables of Model 2 (representing the VPA groups), involved three 
extra explanatory variables. Those represent the statistical interaction, by containing the demeaned (globally, for 
all included subjects), normalized Purkinje cell numbers of the cerebellar lobule 7, multiplied by the group-level 
explanatory variables, respectively. With the proper contrasts, this model allowed for analyzing the groupwise 
correlations between Purkinje cell number and BOLD response, as well as the interaction effects, comparing the 
regression slopes between groups (N = 25 for both measurements).
The resulting group-level statistical maps were corrected for multiple comparisons on the voxelwise-level, 
with a GRF-theory-based maximum height thresholding procedure and thresholded with a significance thresh-
old of P = 0.0571. For the second measurement, a cluster-based thresholding was also applied, with a Z = 3.1 
cluster-forming threshold and a cluster probability cutoff of P = 0.05. This thresholding method, although less 
effective in localizing the activation, was used because the voxelwise thresholding was too conservative for the 
observed lower effect sizes in the group-contrast images of measurement 2.
RoI analysis. In addition to voxel-based analyses, a cerebral and cerebellar ROI was defined, and the indi-
vidual ROI-mean percent BOLD signal change was calculated and compared between groups. These ROIs were 
delineated based on the unbiased F-contrast of Model 1 to avoid favoring any of the groups. This activation map 
was thresholded with a GRF theory-based maximum height thresholding procedure and thresholded with a 
significance threshold of P = 0.05 to identify voxels that were activated in at least one of the groups. The result-
ing activation mask was than multiplied by in-house cerebellum and cerebrum masks to define the cerebellar 
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and cerebral ROIs of activation, respectively. These were used for the ROI-level interaction analysis (Fig. 6). 
These F-contrast based ROIs might not be the most sensitive way to extract information regarding the observed 
interaction-effect, but guarantee unbiased results and eliminate statistical pitfalls.
MRI volumetric and voxel-based morphometry analysis. We used the voxel-based morphometry 
(VBM)-style protocol72 of FSL66, but optimized for the rat brain, as in our previous study61. Nonbrain parts were 
removed from all the structural images66, and tissue-type segmentation was carried out by FAST473. To obtain 
optimal tissue classification, an in-house a priori tissue map61 was used. The volume of whole-brain gray and 
white matter was estimated by taking the sum of the corresponding partial-volume estimate maps.
The resulting gray-matter partial volume images were registered to a standard space using linear transfor-
mation65, followed by a nonlinear registration68. The resulting images were averaged to create a study-specific 
template, to which the native-space gray matter images were then nonlinearly reregistered. The registered partial 
volume images were then modulated (to correct for local expansion or contraction) by being divided with the 
Jacobian of the warp field (incorporating the linear scaling factor, as well). The modulated segmented images were 
then smoothed with an isotropic Gaussian kernel with a sigma of 4 mm. Finally, statistical inference on the treat-
ment effect was performed by voxelwise GLM with permutation-based nonparametric testing (FSL’s randomise). 
Cluster-based belief-boosting was carried out by the TFCE technique74. The images were then thresholded with 
permutation-based empirical maximum height thresholding at a (corrected) significance threshold of P = 0.0571.
Histological processing. Perfusion and preparation of tissue sections. The animals were deeply anesthetized 
using intraperitoneal injection of an anesthetic mixture (containing ketamine, xylazine hydrochloride, promethaz-
inium chloride) and perfused through the heart first with saline (2–3 min) followed by a fixative (30 min) containing 
4% paraformaldehyde in 0.1 M phosphate buffer (PB) (pH 7.4). Brains were removed from the skull and the cerebella 
were dissected and then washed three times in PB. In all cases, sagittal slices from the cerebellar vermis were cut at 
a thickness of 60 μm with a vibratome. After vibratome slicing and extensive washing in 0.1 M PB, the 60 μm-thick 
sections were incubated in 30% sucrose overnight, followed by freeze thawing over liquid nitrogen four times.
Immunocytochemistry. The sections were processed for immunoperoxidase staining. All washing steps and 
dilutions of the antibodies were performed in 0.05 M Tris-buffered saline (TBS), pH 7.4. After extensive wash-
ing in TBS, the sections were blocked in 3% bovine serum albumin for 45 min and then incubated in rabbit 
anti-calbindin-D28kD antibody (1:1000, Swant) for a minimum of 48 h at 4 °C. Following the primary antisera, 
the sections were treated with biotinylated anti-rabbit IgG (1:300) raised in goat for 2 h and then with avidin bioti-
nylated horseradish peroxidase complex (1:500; Elite ABC; Vector Laboratories) for 3 h at room temperature. The 
immunoperoxidase reaction was developed using 3,3′-diaminobenzidine (DAB) as the chromogen.
Purkinje cell quantification. The quantification of cerebellar Purkinje cells is based on the CB immunostained sag-
ittal sections of the cerebellar vermis of 27 rats (9 from each animal group). In general, 8-10 sagittal sections were 
included in the Purkinje cell quantification per animal. Purkinje cells were quantified by counting CB+ cell bodies in 
the Purkinje layer of the entire lobule. After counting the Purkinje cells in a vermal cerebellar lobule, the length of the 
Purkinje cell layer in the lobule was traced and measured by ImageJ software (v1.50b). Then the number of Purkinje 
cells for the given layer (6a, 6b, 6c, 7) was calculated (count/length, traced layer) for 100 μm layer length.
Statistical analysis of brain volumetry, ROI and histological data. Gray and white matter volu-
metry, cerebral and cerebellar ROI and lobule-wise histological data were compared by means of permutation 
testing to overcome possible normality issues. Permutation-based linear models (R-package lmPerm) were fitted 
to explain these data with a factor variable representing the treatment groups. Additionally, for the interaction 
analysis of the cerebral and cerebellar ROIs, the demeaned, normalized Purkinje cell number of the cerebellar 
lobe 7, and its interaction with the group factor variable was also added.
The number of maximum permutations was set to 100000, and factor variables were explicitly set to be han-
dled with the “treatment” contrast of R (traditional “dummy coding”). Permutations were stopped when the 
estimated standard error of the estimated p was less than 0.01*p.
Data Availability
Data generated and analysed during this study are included in this published article and its Supplementary Infor-
mation material, the full datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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